Charles Fogarty, MD

Medical Director
Spartanburg Medical Research, Spartanburg, SC, United States

Disclosure: GSK group of companies (Individual(s) Involved: Self): Grant/Research Support

Presentation(s):

• 119 - A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated

  Oral Abstract

• 121 - A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Immunogenic

  Oral Abstract